Last reviewed · How we verify

NCT06035523

Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™

Completed NA Last updated 28 January 2026
What this trial tests

NA trial testing Endoform™ Antibacterial in Wound Healing in 44 participants. Completed in 30 August 2025.

Timeline
29 December 2021
Primary endpoint
30 August 2025
30 August 2025

Quick facts

Lead sponsorAroa Biosurgery Limited
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment44
Start date29 December 2021
Primary completion30 August 2025
Estimated completion30 August 2025
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Aroa Biosurgery Limited

Who can join

18 and older, any sex, with Wound Healing or Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wound Healing

Currently open trials in the same condition.

Other Aroa Biosurgery Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing